Detalhe da pesquisa
1.
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Blood;
141(25): 3031-3038, 2023 06 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37084383
2.
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
J Natl Compr Canc Netw;
21(1): 12-20, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36634606
3.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
J Natl Compr Canc Netw;
21(11): 1118-1131, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37935098
4.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
J Natl Compr Canc Netw;
19(11): 1218-1230, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34781267
5.
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study.
Biol Blood Marrow Transplant;
26(9): 1679-1688, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32592857
6.
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant;
26(12): 2306-2310, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32961372
7.
Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide.
Biol Blood Marrow Transplant;
26(11): 2075-2081, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32818556
8.
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia.
Biol Blood Marrow Transplant;
26(3): 502-508, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31730920
9.
Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.
J Natl Compr Canc Netw;
18(11): 1571-1578, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33152700
10.
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
18(11): 1537-1570, 2020 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33152694
11.
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant;
25(6): 1128-1135, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30599208
12.
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant;
25(12): 2431-2437, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31394272
13.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood;
129(10): 1389-1393, 2017 03 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28049637
14.
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.
J Natl Compr Canc Netw;
17(6): 650-661, 2019 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31200358
15.
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes.
Biol Blood Marrow Transplant;
24(10): 2056-2064, 2018 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29909152
16.
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation.
Biol Blood Marrow Transplant;
24(5): 1022-1028, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29353109
17.
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors.
Biol Blood Marrow Transplant;
24(5): 1099-1102, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29452245
18.
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.
Biol Blood Marrow Transplant;
23(11): 1903-1909, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28711728
19.
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation.
Biol Blood Marrow Transplant;
23(11): 1887-1894, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28754545
20.
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
Blood;
125(19): 3024-31, 2015 May 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25814532